AbbVie, Inc. (ABBV)
228.49
-1.25
(-0.54%)
USD |
NYSE |
Dec 31, 16:00
230.00
+1.51
(+0.66%)
After-Hours: 20:00
AbbVie Free Cash Flow: 19.68B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Biogen, Inc. | 2.262B |
| Gilead Sciences, Inc. | 9.162B |
| Johnson & Johnson | 20.46B |
| Eli Lilly & Co. | 6.436B |